Insys Must Divest Subsys, Buprenorphine Candidate Products As Part Of Corporate Integrity Agreement
Insys must exit the opioid space as part of a corporate integrity agreement negotiated with the US Justice and Health and Human Services departments. • Source: Shutterstock
